-
-
-
-
-
-
-
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
-
-
-
-
-
-
-
Abeona Therapeutics (ABEO), Taysha Gene Therapies Enter into Licensing and Inventory Purchase Agreements for ABO-202, a Clinical Stage, Novel, One-time Gene Therapy for CLN1 Disease
-
-
-
-
-
-
-
Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors
-
-
-
-
-
-
-
Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
-
-
-
-
-
-
-
After-Hours Stock Movers 10/16: (IMDZ) (TRXC) (IPXL) Higher; (BMI) (ABEO) (SONC) Lower (more...)
-
-
-
-
-
-
-
After-Hours Stock Movers 09/07: (RPRX) (JUNO) (ABEO) Higher; (GEVO) (TSCO) (PIR) Lower (more...)
-
-
-
-
-
-
1,154,893 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

